1.Zalacain R, Torres A. Pneumonia in the elderly. Clinical Pulmonary Medicine 2004;11:210–218.
2.Oh E, Weintraub N, Dhanani S. Can we prevent aspiration pneumonia in the nursing home? J Am Med Dir Assoc 2004;5:174–179.
3.Niederman MS, Brito V. Pneumonia in the older patient. Clin Chest Med 2007;28:751–771.
4.Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–250.
5.Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–382.
6.Nierderman MS, Mandell MA, Anzueto A, et al. American Thoracic Society: guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001;163:645–651.
7.Myint PK, Kamath AV, Vowler SL, et al. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35:286–291.
8.Andrews J, Nadjm B, Gant V, et al. Community-acquired pneumonia. Curr Opin Pulm Med 2003;9:175–180.
9.Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004;59:421–427.
10.Seppa Y, Bloigu A, Honkanen PO, et al. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001;161:2709–2713.
11.Conte HA, Chen YT, Mehal W, et al. A prognostic rule for elderly-patients admitted with community-acquired pneumonia. Am J Med 1999;106:20–28.
12.Naughton BJ, Mylotte JM, Tayara A. Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality. J Am Geriatr Soc 2000;48:1292–1299.
13.Kaplan V, Angus DC, Griffin MF, et al. Hospitalized Community-acquired pneumonia in the elderly: age and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002;165:766–772.
14.Fernandez-Sabe N, Carratala J, Roson B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine 2003;82:159–169.
15.Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998;105:319–330.
16.Mehr DR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J Fam Pract 1992;34:585–591.
17.Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients and pneumonia. J Gen Intern Med 1995;10:246–250.
18.Muder RR, Brennen C, Swenson DL, et al. Pneumonia in a long-term care facility: a prospective study of outcome. Arch Intern Med 1996;156:2365–2370.
19.Torres OH, Munoz J, Ruiz D, et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 2004;52:1603–1609.
20.Cornu C, Yzebe D, Leophonte P, et al. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001;19:4780–4790.
21.Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994;154:2666–2677.
22.Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747–1755.
23.Chiba H, Ohrui T, Matsui T, et al. Benefits of pneumococcal vaccination for bedridden patients. J Am Geriatr Soc 2004;52:1410.
24.Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453–1460.
25.Dear K, Holden J, Andrews R, et al. Vaccines for preventing pneumococcal infection in adults. Cocharane Database Syst Rev 2003;4:CD000422.
26.Loeb M. Pneumonia in the elderly. Curr Opin Infect Dis 2004;17:127–130.
27.Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333–1339.
28.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46:1–25.
29.Kaplan V, Angus DC. Community-acquired pneumonia in the elderly. Crit Care Clin 2003;19:729–748.
30.Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518–527.
31.Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112–124.
32.Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658–666.
33.Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347–382.
34.Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730–1754.
35.Antibiotic working group. Therapeutic guidelines: antibiotic, 13th ed. Melbourne, Therapeutic Guidelines Limited, 2006.
36.Johnson PD, Irving LB, Turnidge JD. Community acquired pneumonia. Med J Aust 2002;176:341–347.
37.Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002;51:709–716.
38.Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc 1997;45:302–306.